Role of RANK ligand in mediating increased bone resorption in early postmenopausal women - Wikidata - awgldk - TriplyDB

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

http://www.wikidata.org/entity/Q34912769

about

Pathogenesis of osteoporosis: concepts, conflicts, and prospects Control of RANKL gene expression Osteoporosis, inflammation and ageing The Role of IL-17 and TH17 Cells in the Bone Catabolic Activity of PTH Hypercalcemia of Malignancy: An Update on Pathogenesis and Management Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts Childhood obesity, bone development, and cardiometabolic risk factors The role of estrogen and androgen receptors in bone health and disease HIV: inflammation and bone Targeting tumor-stromal interactions in bone metastasis Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo Regulation of adult bone turnover by sex steroids Disorders of bone remodeling Effect of dietary legumes on bone-specific gene expression in ovariectomized rats The management of osteoporosis in children.Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures.Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.Identification of genes for complex diseases using integrated analysis of multiple types of genomic data.Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles.Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders.Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1.Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy.Pharmacological management of osteogenesis.Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate.Osteoblast Role in Rheumatic Diseases.Low bone-mineral density in patients with HIV: pathogenesis and clinical significance.Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.Physiology of bone loss.Update on estrogens and the skeleton Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women.How B cells influence bone biology in health and disease Female reproductive system and bone.Emerging therapeutic opportunities for skeletal restoration.The G-protein-coupled receptor GPR103 regulates bone formation.

P2860

Q24536164-74EE6A62-81F2-4724-8FAB-3976E35A4855 Q24619669-6304D9B7-F47C-47DF-9279-8FE476FC4409 Q24815520-A05F5DBC-278D-494B-9613-86D686B8E202 Q26765844-613C3F12-FAAB-49DE-BF2A-4E9F4933A3A8 Q26771719-F4E12CD4-5F96-4FA0-9FF6-A0DF6E665258 Q26801599-65CF0DD0-5F2A-405D-ABE2-17298833C3DC Q26828486-686881DE-344E-4677-8891-8255F19C83CD Q26853091-AC342C73-B81B-41E4-8AE6-6845F8C902D3 Q27008878-4AC6CF46-3D5A-4132-B398-D61DBE8D681B Q27010898-4C842A78-74ED-4B6A-9D77-754D5953D9B0 Q27024561-7B2DD0F8-B565-4D4A-862A-35D212D5CC1C Q28191731-78659738-B23B-4B2F-BD48-9A9D94BE362D Q28281007-F551D769-533B-4C14-B16F-40F8359864A0 Q28295303-D56CB982-2424-4535-814E-6C2F5452CD36 Q28384228-9E4FA293-C7DE-4172-BE32-1E03C4190028 Q30251490-983AD515-3610-4E65-A08B-5C75689E821C Q30476509-4E22E672-2590-4B4C-BE82-3A50C9254D49 Q30478264-19789ADA-8166-413C-975D-6AC5099B44E8 Q30562778-CFF46A43-7C29-4F6E-A93F-B2F3D268EEBB Q30701325-9141252E-AC5C-4412-B0B8-9519BD6FC92E Q33321286-AFBCE12F-3AD1-4EB5-830F-12AEEE288701 Q33511750-41EA4A88-708F-4AD3-BEDB-EA066ED13893 Q33711088-BC39AD5F-93AD-43A2-A7DA-D4F4D286047D Q33729548-AE8C6A9B-525C-41E7-A17E-33477DBCBD02 Q33742652-73231D57-30AE-40D6-922A-046430DEC487 Q33822541-D6197775-EC55-4F86-9A11-C919C50074A9 Q33838967-64453D5E-2EF3-4BB9-9499-C27267ADEA8A Q33844059-90FDDDEA-2944-434A-9FC3-0BF1673A10D6 Q33916514-4B0FE73E-66E4-4112-83D5-BFB3FFE0A3FF Q33980978-DF905E19-4E15-4812-86A7-80422CAA5D81 Q34031994-A5BCC6B5-00DD-41CA-BC1D-02E41B45AC85 Q34044214-21C61401-D4D4-486C-BC49-8B35F52A9205 Q34068440-CEC49AA8-855B-4CC7-924E-97C646B9B11C Q34090842-4025B1A2-9D48-48C4-9CDB-BFD79AA08680 Q34099162-79301E64-36AC-42B3-8E88-3FCB13F10A04 Q34115689-423BB8D4-2C44-48D6-AC68-F425A7EC523E Q34137037-D8408641-FE87-4BA4-A41D-DF1FEF6361F5 Q34142868-1EFFD698-BFC8-447D-82F4-C5E8D4128B17 Q34161867-40DF5E21-63C5-44C8-BF13-905C299693C8 Q34301986-2F5FD5E3-D1BA-49FA-BB4D-6B158925B275

P2860

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

http://www.wikidata.org/entity/Q34912769

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@ast

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@en

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@nl

type

label

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@ast

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@en

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@nl

prefLabel

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@ast

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@en

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@nl

P1433

Q34912769-AAEDD384-BFD9-4809-B977-0A7574B5472C

P1476

Q34912769-A2FBC102-7A5A-43E8-84ED-2D21D1B1EA08

P2093

Q34912769-1529AEF6-985C-4FC0-957A-C702007F9B73

Q34912769-3F93EEB3-F4CF-4DF7-926C-CD4759A1FFB3

Q34912769-4D8DB434-8847-41E3-BD39-72775FECB884

Q34912769-BFB18A36-FEB5-4823-97E6-A8E92DEF1CE3

Q34912769-DCAF0433-B6BA-4271-9184-6E527D913143

P2860

Q34912769-012D6D11-55CC-4828-92FE-2C53A6B03C1E

Q34912769-0338FAEF-5D81-4F4F-8F44-33C8892267C1

Q34912769-056AE619-7146-4CDB-AC15-706100500CCD

Q34912769-0E213A17-C6E6-440A-8181-05C860AC8F89

Q34912769-18F70E1E-1D6D-4FB9-A795-C2E029BC045B

Q34912769-1BA3C479-0634-420F-BC9E-0BBA6E7654F6

Q34912769-1F74C38A-7C84-43EA-88D8-8FD462463B3D

Q34912769-2570FA89-A907-4310-95A0-F40EAF21CAFE

Q34912769-3C06493F-6471-4CD0-A6C4-E980E20DAAC5

Q34912769-4F01EEB7-B2F4-435F-A431-7095976C6A1D

P304

Q34912769-F95736A9-1724-4FEB-8797-84FF57FE6FD2

P31

Q34912769-DBC2873C-317C-48AF-85A2-8E03F617BFC1

P356

Q34912769-F1F7ED73-FEEB-4F64-8262-B4A003E988AC

P407

Q34912769-D5E10BE8-846F-4A36-A7B9-408BAF8F155F

P433

Q34912769-73C5E925-FC9E-4280-A35D-9718365A9521

P478

Q34912769-46788A25-4DCC-48FC-9075-BAD0098C13B7

P50

Q34912769-2C2CF7DE-382D-43B9-8E18-C1F25165C993

P577

Q34912769-7A79B7B6-D706-4F84-820E-5D486BDE1A8D

P698

Q34912769-5119D539-49CB-4A5E-A78E-40C030071744

P932

Q34912769-B54D3CCE-C27A-48E5-915B-2EFF5261AD8A

P356

P1433

Journal of Clinical Investigation

P1476

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women

@en

P2093

Arunik Sanyal

http://www.w3.org/2001/XMLSchema#string

B Lawrence Riggs

http://www.w3.org/2001/XMLSchema#string

David L Lacey

http://www.w3.org/2001/XMLSchema#string

Guitty Eghbali-Fatourechi

http://www.w3.org/2001/XMLSchema#string

William J Boyle

http://www.w3.org/2001/XMLSchema#string

P2860

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor

Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

Stromal stem cells: marrow-derived osteogenic precursors

Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol

P304

1221-1230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200317215

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12697741

http://www.w3.org/2001/XMLSchema#string

P932

152939

http://www.w3.org/2001/XMLSchema#string